Actual Medicinal Product (AMP) Palexia SR 100mg tablets (Grunenthal Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Palexia SR 100mg prolonged-release tablets (Grunenthal Ltd) and Tadomon 100mg prolonged-release tablets (G.L Pharma UK Limited).

Generic
Tapentadol
Formulation
Tapentadol 100mg modified-release tablets
  • Tapentadol
    • Tapentadol 100mg modified-release tablets

      • Palexia SR 100mg tablets (Grunenthal Ltd)